Importance
Vasomotor symptoms in perimenopause are associated with increased future cardiovascular (CVD) risk. Most clinical trials on menopausal hormone therapy (MHT) and CVD risk have focused on postmenopausal women, with limited study of the perimenopausal period when hormonal fluctuations and symptoms are greatest....
Zi-Yuan Wang, S. Swanson, M. Brooks et al.· JAMA Internal Medicine· 1 citation
Obesity management in women requires individualized, life stage-specific approaches integrating lifestyle interventions and pharmacotherapy, and additional research is needed to clarify long-term outcomes and optimize treatment strategies across the lifespan.
Melanie G. Cree, Rebecca Dunsmoor-Su, S. E. El Khoudary et al.· Obesity Pillars· 0 citations
Higher baseline GlycA, rather than its changes since baseline, was associated with lower future working memory, whereas higher baseline complement factor 4 and increases in C3 and C4 since baseline appeared cognitively protective.
Meiyuzhen Qi, C. Derby, Daniel J. Rader et al.· Menopause· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.